BCAL Diagnostics Limited (ASX:BDX)
Australia
· Delayed Price · Currency is AUD 0.115
-0.005 (-4.17%)
Mar 9, 2026, 3:21 PM AEST
BCAL Diagnostics Market Cap
BCAL Diagnostics has a market cap or net worth of 42.40 million as of March 9, 2026. Its market cap has increased by 27.31% in one year.
Market Cap
42.40M
Enterprise Value
42.51M
Revenue
2.54M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.12
Market Cap Chart
Since July 21, 2021, BCAL Diagnostics's market cap has decreased from 51.72M to 42.40M, a decrease of -18.02%. That is a compound annual growth rate of -4.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 42.40M | 9.71% |
| Dec 31, 2025 | 38.65M | 8.87% |
| Dec 31, 2024 | 35.50M | 42.50% |
| Dec 29, 2023 | 24.91M | 96.37% |
| Dec 29, 2022 | 12.69M | -50.95% |
| Dec 29, 2021 | 25.87M | -49.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| INOVIQ | 46.46M |
| Microba Life Sciences | 49.93M |
| Cryosite | 58.57M |
| Rhythm Biosciences | 60.66M |
| Genetic Signatures | 21.58M |
| Imagion Biosystems | 9.81M |
| Monash IVF Group | 257.16M |
| Genetic Technologies | 5.67M |